Citation tools
"177Lu-DOTATATE PRRT as promising new treatment approach in Recurrent Skull Base Phosphaturic Mesenchymal Tumor causing paraneoplastic oncogenic osteomalacia: a potential therapeutic application of PRRT beyond NET." Journal of Nuclear Medicine Technology
(2016):
jnmt.116.177873.
Web. 13 May. 2025.